Timosaponin A3 Induces Anti-Obesity and Anti-Diabetic Effects In Vitro and In Vivo

Pharmacology, Toxicology and Pharmaceutical Science

• Antidiabetic Agent 100%
• Natural Product 100%
• Anemarrhena asphodeloides 100%
• Therapeutic Effect 50%
• Mouse Model 50%
• Hydroxymethylglutaryl Coenzyme A Reductase Kinase 50%
• Glucagon-Like Peptide-1 50%
• Fatty Liver 50%
• Metabolic Disorder 50%
• Sterol Regulatory Element Binding Protein 1c 50%
• Fatty Acid Synthase 50%
• Disease Model 50%
• Cyclic AMP Dependent Protein Kinase Catalytic Subunit 50%
• Non Insulin Dependent Diabetes Mellitus 50%
• Antiobesity Drugs 50%